Amrad Corp., Collateral Therapeutics, Ludwig Institute for Cancer Research deal

Collateral licensed exclusively the human vascular endothelial growth factor B

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE